Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The Europe Sun.
Press releases published on May 28, 2025
All resolutions approved at the 2025 STMicroelectronics' Annual General Meeting of Shareholders
GlobeNewswire
·
May 28, 2025
All resolutions approved at the 2025 STMicroelectronics' Annual General Meeting of Shareholders Amsterdam, May 28, 2025 - STMicroelectronics (NYSE: STM), a global semiconductor leader serving customers across the spectrum of electronics applications, …
Approbation de toutes les résolutions à l’Assemblée Générale Annuelle des Actionnaires 2025 de STMicroelectronics
GlobeNewswire
·
May 28, 2025
Approbation de toutes les résolutions à l’Assemblée Générale Annuelle des Actionnaires 2025 de STMicroelectronics Amsterdam, le 28 mai 2025 - STMicroelectronics (NYSE: STM), un leader mondial des semiconducteurs dont les clients couvrent toute la gamme des …
Scotland triumphs on Italy’s Lake Iseo: Caledonian Braves win fourth edition of the FENIX Trophy, a Brera Holdings event property called “Champions League for amateurs” by BBC Sport
GlobeNewswire
·
May 28, 2025
Victorious Caledonian Braves celebrate Scotland and the team’s win in the FENIX Trophy Championship match over FC United of Manchester earlier this month in Lake Iseo, Italy Dublin, Ireland and Milan, Italy, May 28, 2025 (GLOBE NEWSWIRE) -- Brera Holdings …
BetterLife Pharma Provides Scientific Update on Neuroplastogenic Activity of BETR-001
GlobeNewswire
·
May 28, 2025
VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) (CSE: BETR / OTCQB : BETRF / FRA: NPAU), an emerging biotech company focused on the development of BETR-001, a non-hallucinogenic …
Ventyx Biosciences to Participate in the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
SAN DIEGO, May 28, 2025 (GLOBE NEWSWIRE) -- Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”, “Company”), a clinical-stage biopharmaceutical company focused on developing innovative oral therapies for patients with autoimmune, inflammatory, and …
Milestone Pharmaceuticals to Present at the Jefferies Global Healthcare Conference
GlobeNewswire
·
May 28, 2025
MONTREAL AND CHARLOTTE, N.C., May 28, 2025 (GLOBE NEWSWIRE) -- Milestone® Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Amit Hasija, Chief Financial Officer, and Lorenz Muller, Chief Commercial Officer, will present at the Jefferies Healthcare …
Cocrystal Pharma to Participate in Noble Capital Markets’ 2025 Emerging Growth Virtual Equity Conference
GlobeNewswire
·
May 28, 2025
BOTHELL, Wash., May 28, 2025 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that management will participate in a fireside chat during the Noble Capital Markets’ 2025 Emerging Growth Virtual Equity …
Vaxart Answers Additional Frequently Asked Questions from Retail Investors
GlobeNewswire
·
May 28, 2025
Company Urges Stockholders to Vote FOR Reverse Stock Split Proposal by 11:59 p.m. Eastern Time on June 1, 2025 SOUTH SAN FRANCISCO, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- Vaxart, Inc. (Nasdaq: VXRT) (the “Company” OR “Vaxart”) today answers additional …
Global Leaders Gather for XIII International Meeting on International Cooperation
GlobeNewswire
·
May 28, 2025
MOSCOW, RUSSIA, May 28, 2025 (GLOBE NEWSWIRE) -- A major international venue is hosting the XIII International Meeting of High Representatives Responsible for International Cooperation, bringing together delegations from over 100 countries at the National …
Prime Announces Selection of Ausenco to Lead PEA Study Work
GlobeNewswire
·
May 28, 2025
Preliminary Economic Assessment Targeted for Completion in Q3/2025 [with Clarification of Current Drilling Status] VANCOUVER, British Columbia, May 28, 2025 (GLOBE NEWSWIRE) -- Prime Mining Corp. (“Prime” or the “Company”) (TSX: PRYM) (OTCQX: PRMNF) ( …
Avacta Therapeutics Announces Appointments of Industry Veterans to Board of Directors
GlobeNewswire
·
May 28, 2025
LONDON and PHILADELPHIA, May 28, 2025 (GLOBE NEWSWIRE) -- Avacta Therapeutics (AIM: AVCT), a life sciences company developing next generation peptide drug conjugates (PDC) targeting powerful anti-tumor payloads directly to the tumor, today announces the …
Major Drilling to Release Results for its Fourth Quarter and Fiscal 2025 on June 11, 2025
GlobeNewswire
·
May 28, 2025
MONCTON, New Brunswick, May 28, 2025 (GLOBE NEWSWIRE) -- Major Drilling Group International Inc. (TSX: MDI) (the “Company”) will release its fourth quarter and fiscal 2025 results for the year ended April 30, 2025, on Wednesday, June 11, 2025 after the …
Agios to Present at Goldman Sachs 46th Annual Global Healthcare Conference on June 9, 2025
GlobeNewswire
·
May 28, 2025
CAMBRIDGE, Mass., May 28, 2025 (GLOBE NEWSWIRE) -- Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a leader in cellular metabolism and pyruvate kinase (PK) activation pioneering therapies for rare diseases, today announced that its management team is scheduled …
Entrada Therapeutics Receives Authorization in the European Union to Initiate ELEVATE-45-201, a Phase 1/2 Multiple Ascending Dose Clinical Study of ENTR-601-45 in Patients Living with Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping
GlobeNewswire
·
May 28, 2025
– Company on track to begin ELEVATE-45-201 in Q3 2025 – – Follows recently received Medicines and Healthcare Products Regulatory Agency authorization in the United Kingdom for ELEVATE-45-201 – BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- Entrada Therapeutics, …
NASA Visits Constellium Ravenswood to Celebrate Artemis Partnership
GlobeNewswire
·
May 28, 2025
PARIS, May 28, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) is honored to welcome NASA representatives to its Ravenswood, West Virginia facility today to celebrate their collaboration on the Artemis program — NASA’s bold mission to return humans to …
Harfang intercepte 4,5 g/t Au sur 15,6 m et délimite un nouvel axe minéralisé à haute teneur à Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTRÉAL, 28 mai 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (« Harfang » ou la « Société ») a le plaisir d’annoncer des intersections aurifères additionnelles à haute teneur ainsi que les derniers résultats de son programme inaugural de …
Harfang Intersects 4.5 g/t Au Over 15.6 m and Delineates New High-Grade Mineralized Shoot at Sky Lake, Ontario
GlobeNewswire
·
May 28, 2025
MONTREAL, May 28, 2025 (GLOBE NEWSWIRE) -- Harfang Exploration Inc. (TSX.V: HAR) (“Harfang” or the “Company”) is pleased to announce additional high-grade intercepts and the second batch of results from the 2025 winter diamond drill program (“Winter …
Ocular Therapeutix™ To Close Enrollment This Week for SOL-R, its Second Registrational Trial Evaluating AXPAXLI™ in Wet Age-Related Macular Degeneration
GlobeNewswire
·
May 28, 2025
Enrollment for SOL-R, the largest retinal TKI trial to date, supports randomization of at least 555 subjects SOL-1, Ocular’s first registrational trial in wet AMD, completed randomization in December 2024 and retention remains exceptional as the trial …
BPGbio Presents Advances in Spatial Omics Technology and Targeted Protein Degradation Insights at ASMS 2025
GlobeNewswire
·
May 28, 2025
BOSTON, May 28, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered clinical-stage biopharma company, today announced that the company will present groundbreaking research across five sessions at the 72nd American Society for Mass …
Oragenics, Inc. Announces One-for-Thirty Reverse Stock Split
GlobeNewswire
·
May 28, 2025
SARASOTA, Fla., May 28, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN) (“Oragenics” or the “Company”), a biotech company advancing innovative treatments for brain-related health conditions, today announced that its Board of Directors (the “ …